Rafael Holdings at Guggenheim conference touts npc drug despite trial miss

Scott T. Bauer buys $2,970 in Ames National Corp stock

Investing.com · News 10m ago

Top Yen Forecaster Predicts 147 Per Dollar as Rate Gap Narrows

Bloomberg · Markets 11m ago

Edgewise Therapeutics stock hits all-time high of 48.53 USD

Investing.com · News 11m ago

Moody’s upgrades SM Energy to Ba2 on rapid post-merger deleveraging

Investing.com · News 12m ago

Oculis at guggenheim healthcare conference: precision medicine push

Investing.com · News 14m ago

Defensive healthcare ETFs: broad funds, income options, and key caveats

Investing.com · News 15m ago

Court blocks California from enforcing climate disclosure laws

Investing.com · News 17m ago

Compass Therapeutics at Guggenheim conference: tovecimig faces FDA test

Investing.com · News 18m ago

Entrada Therapeutics at Guggenheim: four data readouts loom

Investing.com · News 19m ago

Coinbase vs. SoFi: The Recent Market Sell-Off Exposes Two Very Different Fintech Risks for 2027

NASDAQ · Markets 21m ago